MENU
+Compare
ABCL
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$3.80
Change
+$0.05 (+1.33%)
Capitalization
1.13B

ABCL AbCellera Biologics Forecast, Technical & Fundamental Analysis

AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner... Show more

ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABCL with price predictions
Jul 03, 2025

ABCL's RSI Indicator soars into overbought territory

The RSI Oscillator for ABCL moved into overbought territory on July 03, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where ABCL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABCL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ABCL broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 30, 2025. You may want to consider a long position or call options on ABCL as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ABCL just turned positive on May 28, 2025. Looking at past instances where ABCL's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

ABCL moved above its 50-day moving average on June 03, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ABCL crossed bullishly above the 50-day moving average on June 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABCL advanced for three days, in of 206 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 108 cases where ABCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.109) is normal, around the industry mean (16.648). P/E Ratio (0.000) is within average values for comparable stocks, (58.447). ABCL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.259). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (48.544) is also within normal values, averaging (268.529).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABCL is expected to report earnings to rise 1.07% to -14 cents per share on August 12

AbCellera Biologics ABCL Stock Earnings Reports
Q2'25
Est.
$-0.14
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.01
The last earnings report on May 08 showed earnings per share of -14 cents, missing the estimate of -12 cents. With 1.95M shares outstanding, the current market capitalization sits at 1.13B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2215 Yukon Street
Phone
+1 604 559-9005
Employees
586
Web
https://www.abcellera.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCGFX13.540.15
+1.12%
AMG Montrusco Bolton Large Cap Growth N
MALVX32.340.21
+0.65%
BlackRock Advantage Large Cap Val Instl
RGESX11.030.07
+0.64%
Russell Inv Global Equity S
OTIIX57.360.36
+0.63%
T. Rowe Price Small-Cap Stock I
SHEAX9.730.06
+0.62%
American Beacon Shapiro SMID Cap Eq A

ABCL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.33%
CRSP - ABCL
62%
Loosely correlated
+0.97%
RXRX - ABCL
61%
Loosely correlated
+1.15%
ABSI - ABCL
57%
Loosely correlated
+2.97%
BEAM - ABCL
57%
Loosely correlated
+0.65%
NTLA - ABCL
57%
Loosely correlated
+0.09%
More